71 related articles for article (PubMed ID: 38449612)
1. Trilobolide-6-O-isobutyrate exerts anti-tumor effects on cholangiocarcinoma cells through inhibiting JAK/STAT3 signaling pathway.
Zhang HX; Fan R; Chen QE; Zhang LJ; Hui Y; Xu P; Li SY; Chen GY; Chen WH; Shen DY
Heliyon; 2024 Mar; 10(5):e27217. PubMed ID: 38449612
[TBL] [Abstract][Full Text] [Related]
2. Trilobolide-6-O-isobutyrate suppresses hepatocellular carcinoma tumorigenesis through inhibition of IL-6/STAT3 signaling pathway.
Zhou XQ; Mao XM; Fan R; Li SY; Shang J; Zhang T; Li RH; Li HQ; Hui Y; Chen WH; Wang ZX; Shen DY
Phytother Res; 2021 Oct; 35(10):5741-5753. PubMed ID: 34355433
[TBL] [Abstract][Full Text] [Related]
3. Trilobolide-6-O-isobutyrate from Sphagneticola trilobata acts by inducing oxidative stress, metabolic changes and apoptosis-like processes by caspase 3/7 activation of human lung cancer cell lines.
Concato-Lopes VM; Gonçalves-Lens MD; Tomiotto-Pellissier F; Detoni MB; Cruz EMS; Bortoleti BTDS; Carloto ACM; Rodrigues ACJ; Silva TF; Siqueira EDS; de Matos RLN; Alves Cardoso IL; Conchon-Costa I; Lazarin-Bidóia D; Arakawa NS; Dekker RFH; Mantovani MS; Pavanelli WR
Phytomedicine; 2024 Jun; 128():155536. PubMed ID: 38513379
[TBL] [Abstract][Full Text] [Related]
4. Allicin Inhibits Proliferation and Invasion in Vitro and in Vivo via SHP-1-Mediated STAT3 Signaling in Cholangiocarcinoma.
Chen H; Zhu B; Zhao L; Liu Y; Zhao F; Feng J; Jin Y; Sun J; Geng R; Wei Y
Cell Physiol Biochem; 2018; 47(2):641-653. PubMed ID: 29794468
[TBL] [Abstract][Full Text] [Related]
5. Cryptotanshinone induces cell cycle arrest and apoptosis through the JAK2/STAT3 and PI3K/Akt/NFκB pathways in cholangiocarcinoma cells.
Ke F; Wang Z; Song X; Ma Q; Hu Y; Jiang L; Zhang Y; Liu Y; Zhang Y; Gong W
Drug Des Devel Ther; 2017; 11():1753-1766. PubMed ID: 28670110
[TBL] [Abstract][Full Text] [Related]
6. Luteolin arrests cell cycling, induces apoptosis and inhibits the JAK/STAT3 pathway in human cholangiocarcinoma cells.
Aneknan P; Kukongviriyapan V; Prawan A; Kongpetch S; Sripa B; Senggunprai L
Asian Pac J Cancer Prev; 2014; 15(12):5071-6. PubMed ID: 24998588
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of USP1 activates ER stress through Ubi-protein aggregation to induce autophagy and apoptosis in HCC.
Wang L; Hu T; Shen Z; Zheng Y; Geng Q; Li L; Sha B; Li M; Sun Y; Guo Y; Xue W; Xuan D; Chen P; Zhao J
Cell Death Dis; 2022 Nov; 13(11):951. PubMed ID: 36357365
[TBL] [Abstract][Full Text] [Related]
8. Lactylation-driven METTL3-mediated RNA m
Xiong J; He J; Zhu J; Pan J; Liao W; Ye H; Wang H; Song Y; Du Y; Cui B; Xue M; Zheng W; Kong X; Jiang K; Ding K; Lai L; Wang Q
Mol Cell; 2022 May; 82(9):1660-1677.e10. PubMed ID: 35320754
[TBL] [Abstract][Full Text] [Related]
9. RNA binding protein NKAP protects glioblastoma cells from ferroptosis by promoting SLC7A11 mRNA splicing in an m
Sun S; Gao T; Pang B; Su X; Guo C; Zhang R; Pang Q
Cell Death Dis; 2022 Jan; 13(1):73. PubMed ID: 35064112
[TBL] [Abstract][Full Text] [Related]
10. The JAK/STAT signaling pathway: from bench to clinic.
Hu X; Li J; Fu M; Zhao X; Wang W
Signal Transduct Target Ther; 2021 Nov; 6(1):402. PubMed ID: 34824210
[TBL] [Abstract][Full Text] [Related]
11. SARS-CoV-2 N Protein Induces Acute Kidney Injury via Smad3-Dependent G1 Cell Cycle Arrest Mechanism.
Wang W; Chen J; Hu D; Pan P; Liang L; Wu W; Tang Y; Huang XR; Yu X; Wu J; Lan HY
Adv Sci (Weinh); 2022 Jan; 9(3):e2103248. PubMed ID: 34813685
[TBL] [Abstract][Full Text] [Related]
12. FOXM1 inhibitor, Siomycin A, synergizes and restores 5-FU cytotoxicity in human cholangiocarcinoma cell lines via targeting thymidylate synthase.
Klinhom-On N; Seubwai W; Sawanyawisuth K; Obchoei S; Mahalapbutr P; Wongkham S
Life Sci; 2021 Dec; 286():120072. PubMed ID: 34688691
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
